As our understanding of conformational chemistry advances, we can explore a variety of strategies beyond cyclization to restrict the number of low-energy conformations accessible to ligands. These alternative approaches offer the potential to optimize binding affinity and enhance the overall pharmacological profile of ligands, facilitating more efficient drug design and discovery.

In this comprehensive review we highlighted the essential role of conformational drivers in drug design, exploring how molecular conformation influences key drug properties with real-world examples.